- This topic is empty.
-
Posts
-
-
This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Thursday, February 29, 2024. It also contains links to CNBC sites which contain video clips and transcripts.
(1) Jim Cramer explains why the market rallied on Thursday (https://www.cnbc.com/2024/02/29/jim-cramer-explains-why-the-market-rallied-on-thursday.html)
- CNBC’s Jim Cramer told investors why he thinks the market was able to rally on Thursday, citing continued momentum in the tech sector and tepid inflation data.
- “What mattered was the one-two punch of an economy that’s just right—meaning still potentially ripe for rate cuts, it could happen—and the fact that AI is alive and well,” he said. “It reminded us why you can’t leave stocks, even if you think we’ve had a nice run so far this year and it’d be safer to move to the sidelines.”
Ticker: SNOW, CRM, HPQ, BBY, AAPL
(2) Executive Interview: CEO says Hormel Foods is well-positioned as weight-loss drugs grow popular (https://www.cnbc.com/2024/02/29/ceo-says-hormel-foods-is-well-positioned-as-weight-loss-drugs-get-big.html)
- Hormel Foods CEO Jim Snee told CNBC’s Jim Cramer his company’s varied “protein portfolio” is advantageous as weight-loss drugs gain popularity.
- The company is known for brands like Planters, Skippy, Justin’s and Spam.
Ticker: HRL
(3) [No Video Clip for non-Club members] I’m expecting bigger gains on Abbott, says Jim Cramer (https://www.cnbc.com/video/2024/02/29/im-expecting-bigger-gains-on-abbott-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer takes a closer look at Abbott Labs.
Ticker: ABT [Charitable trust sold in 2022, et back ini],
(4) [No Video Clip for non-Club members] Sempra CEO Jeffrey Martin sits down with Jim Cramer (https://www.cnbc.com/video/2024/02/29/sempra-ceo-jeffrey-martin-sits-down-with-jim-cramer.html)
Sempra Chairman, President and CEO Jeffrey Martin joins ‘Mad Money’ host Jim Cramer to talk the energy sector, its capital allocation plan, leaded natural gas and more.
Ticker: SRE
(5) Cramer’s Lightning Round: Signet Jewelers is a winner (https://www.cnbc.com/2024/02/29/cramers-lightning-round-signet-jewelers-is-a-winner.html)
- Signet Jewelers: “I think Gina Drosos is doing a remarkable job…You’ve got a winner there.”
- Equinix: “I can’t recommend it, it’s just up so much…But I do like it very much.”
- Infosys: “Smart consulting company…I like the stock.”
- Commercial Metals: “It’s a winner.”
- Amkor: “You got a winner.”
- Arm: “There is going to be what’s known as a lock-up expiration where Softbank is going to be able to sell a lot of stock…If you want to buy some right now and then wait for that lock-up to end.”
Ticker: SIG, EQIX, INFY, CMC, AMKR, ARM
(6) [No Video Clip for non-Club members] Jim Cramer talks how to invest when it comes to weight-loss drugs (https://www.cnbc.com/video/2024/02/29/jim-cramer-talks-how-to-invest-when-it-comes-to-weight-loss-drugs.html)
‘Mad Money’ host Jim Cramer talks investing trends around the weight-loss industry.
Other Stocks Discussed (calls with audience): Roblox (RBLX) [I like RBLX], CrowdStrike (CRWD) [stay long, do not sell], Cava Group (CAVA) [stay long, let it run], CRISPR Therapeutics (CRSP) [sell a quarter position rather than sell call option], AVITA Medical (RCEL) [don’t know the stock]
Ref: Links to other sites that relate to episode of February 29, 2024
- Podcast at Spotify (Sound from Spotify）
- Internet Archive（Video & Texts per minute）
****************************
Previous episode Next Episode
-
- The topic ‘Mad Money: Key points from February 29, 2024 (Thursday) Episode’ is closed to new replies.